---
figid: PMC3783819__jbr-27-05-345-g002
figtitle: 'Pathogenesis of RON receptor tyrosine kinase in cancer cells: activation
  mechanism, functional crosstalk, and signaling addiction'
organisms:
- NA
pmcid: PMC3783819
filename: jbr-27-05-345-g002.jpg
figlink: /pmc/articles/PMC3783819/figure/jbr-27-05-345-g002/
number: F2
caption: Activation of RON is mediated by MSP binding, overexpression, splicing/truncation,
  and point mutations. Upon activation, the C-terminal docking site recruits cytoplasmic
  molecules son of sevenless (SOS) and growth factor receptor-bound protein (GRB2)
  to initiate two classical signaling pathways, Ras-MAPK and PI-3K-AKT. The RAS-MAPK
  pathway regulates RON-mediated cell growth, survival, and invasiveness. Activated
  Erk1/2 also stimulates p90 ribosomal S6 kinase (RSK)-2 to regulate gene transcription
  and cytoskeleton reorganization to cause EMT. The PI-3K-AKT pathway regulates RON-mediated
  cell shape change, migration and matrix invasion. It also stimulates mTOR signaling
  to promote HIF-1α activation for gene transcription. AKT also stimulates 14-3-3
  phosphorylation, which regulates α6β4 integrin for cell motility. CM, cell membrane;
  ELK-1, ETS domain-containing protein-1; Erk, extracellular signal-regulated kinase;
  MITF, microphthalmia-associated transcription factor; mTOR, mammalian target of
  rapamycin; NM nuclear membrane, SRF, specific response factors.
papertitle: 'Pathogenesis of RON receptor tyrosine kinase in cancer cells: activation
  mechanism, functional crosstalk, and signaling addiction.'
reftext: Ming-Hai Wang, et al. J Biomed Res. 2013 Sep;27(5):345-356.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9064814
figid_alias: PMC3783819__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC3783819__F2
ndex: 09667925-df11-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3783819__jbr-27-05-345-g002.html
  '@type': Dataset
  description: Activation of RON is mediated by MSP binding, overexpression, splicing/truncation,
    and point mutations. Upon activation, the C-terminal docking site recruits cytoplasmic
    molecules son of sevenless (SOS) and growth factor receptor-bound protein (GRB2)
    to initiate two classical signaling pathways, Ras-MAPK and PI-3K-AKT. The RAS-MAPK
    pathway regulates RON-mediated cell growth, survival, and invasiveness. Activated
    Erk1/2 also stimulates p90 ribosomal S6 kinase (RSK)-2 to regulate gene transcription
    and cytoskeleton reorganization to cause EMT. The PI-3K-AKT pathway regulates
    RON-mediated cell shape change, migration and matrix invasion. It also stimulates
    mTOR signaling to promote HIF-1α activation for gene transcription. AKT also stimulates
    14-3-3 phosphorylation, which regulates α6β4 integrin for cell motility. CM, cell
    membrane; ELK-1, ETS domain-containing protein-1; Erk, extracellular signal-regulated
    kinase; MITF, microphthalmia-associated transcription factor; mTOR, mammalian
    target of rapamycin; NM nuclear membrane, SRF, specific response factors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Msp
  - SP
  - nmd
  - pnt
  - cm
  - Sos
  - drk
  - Act5C
  - Act42A
  - Act57B
  - Act79B
  - Act88F
  - Act87E
  - 14-3-3zeta
  - 14-3-3epsilon
  - Mtor
  - Tor
  - rl
  - B4
  - Prosbeta4
  - Prosbeta7
  - betaTub97EF
  - scb
  - cher
  - sima
  - S6kII
  - Mitf
  - Jra
  - kay
  - Srf
  - mal
  - bs
  - tgo
  - MSMB
  - MST1
  - TMPRSS13
  - LMLN
  - MST1R
  - XYLT2
  - SOS1
  - SOS2
  - GRB2
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - YWHAQ
  - MTOR
  - MAPK3
  - MAPK1
  - TUBB3
  - AP4B1
  - BHLHE23
  - HIF1A
  - RPS6KA3
  - RPS6KA1
  - NM
  - MITF
  - JUN
  - JUNB
  - JUND
  - FOS
  - FOSB
  - FOSL1
  - FOSL2
  - SRF
  - ELK1
  - KCNH4
  - KCNH8
  - ARNT
---
